WealthCollab’s Vertex Pharmaceuticals VRTX Stock Holding History

WealthCollab’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.25K	Sell	14 -6	-30%	-$2.8K	﹤0.01%	635
2025 Q4	$9.07K	Buy	20 +6	+43%	+$2.59K	﹤0.01%	586
2025 Q3	$5.48K	Hold	14	–	–	﹤0.01%	661
2025 Q2	$6.23K	Hold	14	–	–	﹤0.01%	585
2025 Q1	$6.79K	Hold	14	–	–	﹤0.01%	551
2024 Q4	$5.64K	Hold	14	–	–	﹤0.01%	568
2024 Q3	$6.51K	Hold	14	–	–	﹤0.01%	556
2024 Q2	$6.56K	Hold	14	–	–	﹤0.01%	521
2024 Q1	$5.85K	Hold	14	–	–	﹤0.01%	549
2023 Q4	$5.7K	Buy	+14	New	+$5.17K	﹤0.01%	533

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

WealthCollab's VRTX Position: Q1 2026 in Review

WealthCollab reduced its Vertex Pharmaceuticals (VRTX) stake by 30% in Q1 2026, selling an estimated $2.8K and leaving 14 shares worth $6.25K. The position accounts for ﹤0.01% of the portfolio, ranked #635.

WealthCollab first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $9.07K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

WealthCollab held 14 shares of Vertex Pharmaceuticals worth $6.25K as of Q1 2026.
WealthCollab sold 6 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.8K.
Vertex Pharmaceuticals made up ﹤0.01% of WealthCollab's portfolio in Q1 2026, its #635 holding.
WealthCollab first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
WealthCollab's Vertex Pharmaceuticals position peaked at $9.07K in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.